EPIC: Evaluation of Pharmacy-based Identification and Treatment of HCV
- Disease/Condition
- Hepatitis C
- Drug/Device/Intervention
- Hepatitis C Point of Care Testing and Treatment
- Study type
- Interventional
- Intervention type
- diagnostic test
- Primary sponsor
- Cool Aid Community Health Centre
- Location
- Victoria, Canada
- Phase
- N/A
- Start date
- Jul 13, 2020
- End date
- Apr 01, 2023
- Enrollment
- 200 participants
HCV access to care for HCV testing and treatment
The research project aims to understand how pharmacies can be involved in the identification
 and treatment of hepatitis C (hep C). The study will look at the effectiveness of hep C
 testing and treatment through pharmacies with support from the Cool Aid Community Health
 Centre (CACHC). The study will also evaluate the readiness of pharmacies to take on these
 extra tasks at the pharmacy. This information will be used to develop future strategies to
 better detect, treat and prevent hep C.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT05412017
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT05412017 through Pure Global AI's free database. This phase not specified trial is sponsored by Cool Aid Community Health Centre and is currently Recruiting. The study focuses on Hepatitis C. Target enrollment is 200 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.